Published in Eur J Health Econ on June 16, 2015
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA (2007) 7.11
Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA (2007) 6.51
Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood) (2008) 6.13
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J (2008) 3.40
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation (2009) 3.39
Value-based insurance design. Health Aff (Millwood) (2007) 3.27
Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med (2005) 2.60
Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med (2012) 2.54
A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. Am J Manag Care (2001) 2.44
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation (2008) 2.42
Measuring concurrent adherence to multiple related medications. Am J Manag Care (2009) 1.88
Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J (2013) 1.87
Value-based insurance design: quality improvement but no cost savings. Health Aff (Millwood) (2013) 1.81
The impact of reducing cardiovascular medication copayments on health spending and resource utilization. J Am Coll Cardiol (2012) 1.58
Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf (2008) 1.45
Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Aff (Millwood) (2007) 1.45
Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med (2009) 1.41
Medication adherence in cardiovascular disease. Circulation (2010) 1.39
Value-based insurance design: a "clinically sensitive" approach to preserve quality of care and contain costs. Am J Manag Care (2006) 1.22
Evidence that value-based insurance can be effective. Health Aff (Millwood) (2010) 1.17
The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol (2003) 1.06
The use of an automated patient registry to manage and monitor cardiovascular conditions and related outcomes in a large health organization. Int J Cardiol (2010) 1.00
The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin (2008) 0.99
Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension. Med Care (2013) 0.99
Five features of value-based insurance design plans were associated with higher rates of medication adherence. Health Aff (Millwood) (2014) 0.90
Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertens Res (2013) 0.88
Systematic review of model-based analyses reporting the cost-effectiveness and cost-utility of cardiovascular disease management programs. Eur J Cardiovasc Nurs (2014) 0.81
Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings. Pharmacotherapy (2013) 0.81
Cost-effectiveness of enhancing adherence to therapy with blood pressure-lowering drugs in the setting of primary cardiovascular prevention. Value Health (2013) 0.79
Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation model. PLoS Med (2010) 0.79